Innate lymphoid cells have a clear role in rheumatic disease and its related inflammatory process.
In this article, we highlight some of the most important pharma reports presented at ACR 2016 this year.
Gout patients who successfully respond to urate lowering therapy have higher rates of chronic kidney disease improvement, a study shows.
Gout and rheumatoid arthritis are both associated with premature mortality, researchers report.
CPPD disease, once known as pseudogout, is underdiagnosed. A thorough analysis of synovial fluid can help improve outcomes, researchers say.
In 2015, ACR and EULAR issued classification criteria for gout. The scoring system is summarized here in an easy to use format for physicians and patients.
Few gout patients know their serum urate goals, which researchers say could hinder their chances of reaching remission.
A new study attempts to find consensus on a challenging problem: When is gout considered to be in remission?
Sleep apnea and gout have a lot in common: Both are associated with an increased level of uric acid and the incidence of gout.
Maintaining normal serum urate concentrations can prevent tophi formation in gout reducing cardiovascular risk factors.